ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 466,81
0,19%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Olink Holding AB (OLK)

  7. Olink Holding AB (OLK) Actualités

OLK

Olink Holding AB (OLK)

Olink Holding AB
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OLK
DateHeureSourceTitreSymboleSociété
06/06/202408h00GlobeNewswire Inc.Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute ConfidenceNASDAQ:OLKOlink Holding AB
30/05/202414h00GlobeNewswire Inc.Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before DiagnosisNASDAQ:OLKOlink Holding AB
13/05/202412h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OLKOlink Holding AB
13/05/202412h00GlobeNewswire Inc.Olink reports first quarter 2024 financial resultsNASDAQ:OLKOlink Holding AB
19/04/202422h05GlobeNewswire Inc.Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024NASDAQ:OLKOlink Holding AB
02/04/202414h00GlobeNewswire Inc.Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of DiseaseNASDAQ:OLKOlink Holding AB
25/03/202413h00GlobeNewswire Inc.Olink reports fourth quarter and full year 2023 financial resultsNASDAQ:OLKOlink Holding AB
25/03/202413h00GlobeNewswire Inc.Olink publishes 2023 annual reportNASDAQ:OLKOlink Holding AB
15/03/202413h00GlobeNewswire Inc.Notice to attend the Annual General Meeting of Olink Holding AB (publ)NASDAQ:OLKOlink Holding AB
08/03/202414h00GlobeNewswire Inc.Olink announces change of date for Annual General MeetingNASDAQ:OLKOlink Holding AB
01/03/202422h45Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:OLKOlink Holding AB
15/11/202313h00GlobeNewswire Inc.Olink reports third quarter 2023 financial resultsNASDAQ:OLKOlink Holding AB
06/11/202302h00GlobeNewswire Inc.Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomicsNASDAQ:OLKOlink Holding AB
31/10/202316h36Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:OLKOlink Holding AB
18/10/202300h40Business WireThermo Fisher Scientific prépare l'acquisition d'Olink, leader de la protéomique de nouvelle générationNASDAQ:OLKOlink Holding AB
18/10/202300h39Business WireThermo Fisher Scientific übernimmt Olink, ein führendes Unternehmen der Proteomik der nächsten GenerationNASDAQ:OLKOlink Holding AB
17/10/202323h28Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:OLKOlink Holding AB
17/10/202316h16Dow Jones NewsOlink Holding Shares Soar on Takeover by Thermo FisherNASDAQ:OLKOlink Holding AB
17/10/202315h01Dow Jones NewsThermo Fisher to Buy Olink in $3.1 Billion DealNASDAQ:OLKOlink Holding AB
17/10/202314h19Business WireThermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation ProteomicsNASDAQ:OLKOlink Holding AB
05/10/202322h25GlobeNewswire Inc.Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomicsNASDAQ:OLKOlink Holding AB
19/09/202309h00GlobeNewswire Inc.Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.NASDAQ:OLKOlink Holding AB
12/09/202317h00GlobeNewswire Inc.Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programsNASDAQ:OLKOlink Holding AB
29/08/202314h00GlobeNewswire Inc.Olink to participate in September investor eventsNASDAQ:OLKOlink Holding AB
18/08/202302h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLKOlink Holding AB
09/08/202313h00GlobeNewswire Inc.Olink reports second quarter 2023 financial resultsNASDAQ:OLKOlink Holding AB
08/08/202314h00GlobeNewswire Inc.Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platformNASDAQ:OLKOlink Holding AB
13/07/202314h00GlobeNewswire Inc.Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:OLKOlink Holding AB
12/07/202315h00GlobeNewswire Inc.Announcing Olink® Explore HT – A New Era in ProteomicsNASDAQ:OLKOlink Holding AB
28/06/202314h00GlobeNewswire Inc.Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studiesNASDAQ:OLKOlink Holding AB
 Showing the most relevant articles for your search:NASDAQ:OLK

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
MC
Lvmh Moet Hennessy Louis...
EU
AF
Air FranceKLM
EU
CS
Axa
USI
USTECH100
US Tech 100
EU
DG
Vinci
EU
RNO
Renault
EU
RI
Pernod Ricard
EU
HO
Thales
EU
LR
Legrand
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
EU
CAP
Capgemini
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés